Abstract
Chemical compounds in an ever-increasing variety and kind are constantly being introduced into the human environment. Some of these may affect the genetic material. Such effects, when produced in germ cells, lead to an increase of the genetic load of our descendants, while in somatic cells they may result in the development of malignancies. Recent findings suggest a striking overlap between the mutagenic and carcinogenic potential of chemicals that a distinction between the two tends to become an artificial one.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
F. J. De Serres, The correlation between carcinogenic and mutagenic activity in short-term tests for mutation induction and DNA repair, Mutat. Res. 31, 203 (1975).
B. Bridges, The three-tier approach to mutagenicity screening and the concept of radiation-equivalent dose, Mutat. Res. 26, 335 (1974).
S. Abrahamson, and E. B. Lewis, The detection of mutations in Drosophila melanogaster, in: “Chemical mutagens. Principals and Methods for Their Detection” (A. Hollaender ed.), p. 461, Plenum Press, New York (1971).
H. J. Muller and I. I. Oster, Some mutational techniques in Drosophila, in: “Methodology in Basic Genetics” (W. J. Burdette, ed.) p. 249, Holden-Day Inc., San Francisco (1963).
W. R. Lee, Chemical mutagenesis, in: “The Genetics and Biology of Drosophila” (M. Ashburner and E. Novitski, eds.). Academic Press, New York (1975).
F. H. Sobels, The role ofDrosophila in the field of mutation research. Arch. Genet. 45, 101 (1972).
F. H. Sobels, The advantages ofDrosophila for mutation studies, Mutat. Res. 26, 111 (1974).
F. E. Würgler, F. H. Sobels, and E. Vogel, Drosophila tests, Mutat. Res., 1975, in press.
J. E. Casida, Insect microsomes and insecticide chemical oxidations, in: “Microsomes and Drug Oxidations,” p. 517Academic Press, New York (1969).
E. Hodgson, and F. W. Plapp, Biochemical characteristics of insect microsomes, J. Agr. Food Chem. 18, 1048 (1970).
C. F. Wilkinson, and L. B. Brattsten, (1972), Microsomal drug metabolizing enzymes in insects, Drug Metab. Reviews 1 (2), 153.
H. S. Mason, J. C. North, and M. Vanneste, (1965), Microsomal mixed-function oxidations: the metabolism of xenobiotics, Fedn. Proc. 24, 1172.
L. G. Hansen, and E. Hodgson, (1971), Biochemical characteristics of insect microsomes, N- and O-demethylation, Biochem. Pharm. 20, 1569.
J. H. Dewaide, (1971), Metabolism of Xenobiotics. Comparative and kinetic studies as a basis for environmental pharmacology. Thesis, University Nijmegen.
H. S. Mason, Mechanisms of oxygen metabolism, in: “Advances in Enzymology” (Nord, F. F. ed.) pp. 19, 79, Interscience Publishers Inc., New York (1957).
D. V. Parke, “The Biochemistry of Foreign Compounds,” p. 261, Pergamon Press, Oxford (1968).
L. Shuster, Metabolism of drugs and toxic substances, Ann. Rev. Biochem. 33, 571 (1964).
R. T. Williams, “Detoxication Mechanisms,” Wiley, New York (1959).
M. Tsukamoto, Metabolic fate of DDT in Drosophila melanogaster. I. Identification of a non-DDE metabolite, Botyu-Kagaku 24, 141 (1959).
M. Tsukamoto, Metabolic fate of DDT in Drosophila melanogaster. II. DDT resistance and Kelthane production, Botyu-Kagaku 25, 156 (1960).
M. Tsukamoto, Metabolic fate of DDT in Drosophila melanogaster. III. Comparative studies, Botyu-Kagaku 26, 74 (1961).
A. W. A. Brown, Genetics of insecticide resistance in insect vectors, in: “Genetics of Insect Vection of Disease” (J. W. Wright and R. Pal eds.), p. 505, Elsevier, Amsterdam (1967).
F. J. Oppenoorth, Biochemical genetics of insecticide resistance, Ann. Rev. Entomol. 10, 185 (1965).
P. N. Magee and J. M. Barnes, The production of malignant primary liver tumours in the rat by feeding dimethylnitrosamine, Brit. J. Cancer 10, 114 (1956).
E. C. Miller and J. A. Miller, The mutagenicity of chemical carcinogens: Correlations, problems, and interpretations, in:“Chemical mutagens, Principles and Methods for Their Detection” (A. Hollaender, ed.), p. 83, Plenum Press, New York (1971).
J. A. Miller, Carcinogenesis by chemicals: An overview. G.H.A. Crowes Memorial Lecture, Cancer Res. 38, 559 (1971).
R. Preussmann, Zum Wirkungsmechanismus karzinogener Aryldialkyltriazene, Fortschr. Krebsforsch., p. 163 (1969).
H. Druckrey, R. Preussmann, S. Ivankovic, D. Schmähl, I. Afkham, G. Blum, H. D. Mennel, M. Müller, P. Petropoulos, and H. Schneider, Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten, Z. Krebsforsch. 69, 103 (1967).
P. N. Magee and R. Schoental, Carcinogenesis by nitroso compounds, Brit. Med J. 20, 102 (1964).
R. Preussmann, H. Druckrey, S. Ivankovic, and A. von Hodenberg, Chemical structure and carcinogenicity of aliphatic hydrazo, azo, and azoxy compounds and of triazenes, potentialin vivo alkylating agents, Ann. N.Y. Acad. Sci. 163, 797 (1969).
R. Preussmann, A. von Hodenberg, and H. Hengy, Mechanism of carcinogenesis with l-aryl-3,3-dialkyltriazenes. Enzymatic dealkylation by rat liver microsomal fraction in vitro, Biochem. Pharmacol. 18, 1 (1969).
H. Druckrey, Chemische Struktur und Reaktionsmechanismen krebserzeugender Substanzen, Umsch. Wiss. Tech. p. 94 (1972).
P. D. Lawley and C. J. Thatcher, Methylation of deoxyribonucleic acid in cultured mammalian cells by N-methyl-N-nitro-N-nitrosoguanidine, Biochem. J. 116, 696 (1970).
I. A. Rapoport, The alkylation of the gene molecule, Dokl. Akad. Nauk SSSR 59, 1183 (1948).
C. Auerbach and B.J. Kilbey, Mutation in eukaryotes, Ann. Rev. Genet. 5, 163 (1971).
W. Lijinsky and A. E. Ross, Alkylation of rat liver nucleic acids not related to carcinogenesis by N-nitrosamines, J. Nat. Cancer Inst. 42, 1095 (1969).
G. F. Kolar and R. Preussmann, Validity of a linear Hammet plot for the stability of some carcinogenic l-aryl-3,3-dimethyltriazenes in an aqueous system, Z. Naturorsch 26b, 950(1971).
F. W. Krüger, R. Preussmann, and N. Niepelt, Mechanism of carcinogenesis with 1-aryl-3, 3-dialkyl-triazenes. III. In vitro methylation of RNA and DNA with 1-phenyl-3,3(14C)-dimethyltriazene, Biochem. Pharmakol. 20, 529 (1971).
G. F. Kolar, Biologically active derivatives of 1,3-triazene, in “Advances in Antimicrobial and Antineoplastic Chemotherapy,” Proc. of the VIIth Int. Congr. Of Chemotherapy, (M. Hejzlar, M. Semonsky and S. Masak, eds.), Prague, Urban und Schwarzenberg, München, 1972 p. 121 (1971).
W. Kreis, S. B. Peipho, and H. V. Bernhard, Studies on the metabolic fate of the 14-C-labeled methyl group of a methyl hydrazine derivative in P815 mouse leukemia, Experienta 22, 431 (1966).
W. Kreis, J. H. Burchenal, and D. J. Hutchinson, Influence of a methylhydrazine derivative on thein vivo transmethylation of the S-methyl group of methionine onto purine and pyrimidine bases of RNA, Proc. Am. Assoc. Cancer Res. 9, 38, (1968).
H. J. Teas, and J. G. Dyson, Mutations in Drosophila by methylazoxymethanol, the aglycone of cycasin, Proc. Soc. Exp. Biol. Med. 125, 988 (1967).
N. Brock, Pharmakologische Untersuchungen mit Trofosfamid (Ixoten®), einem neuen Oxazaphosphorinoxid, Med. Monatsschr. 27, 390 (1973).
N. Brock, R. Gross, H. J. Hohorst, H. O. Klein, and B. Schneider, Activation of cyclophosphamide in man and animals, Cancer 27, 1512 (1971).
N. Brock, and H. J. Hohorst, Über die Aktivierung von Cyclophosphamidin vivo und in vitro, Arzneimittel-Forsch. 13, 1021 (1963).
N. Brock, and H. J. Hohorst, (1967), Metabolism of cyclophosphamide, Cancer 20, 900.
N. Brock, H. Hoefer-Janker, H. J. Hohorst, W. Scheef, B. Schneider, and H. C. Wolf, (1973), Die Aktivierung von Ifosfamid an Mensch und Tier, Arzeim.-Forsch. 23, 1.
N. E. Sladek, Therapeutic efficacy of cyclophosphamide as a function of its metabolism, Cancer Res. 535 (1972).
T. A. Connors, P. J. Cox, P. B. Farmer, A. B. Foster, and M. Jarman, Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and ifosfamide, Pharmacol. 23, 115 (1974).
D. L. Hill, W. R. Laster, Jr., and R. F. Struck, Enzymatic metabolism of cyclophosphamide and nicotine and production of a toxic cyclophosphamide metabolite. Cancer 658 (1972).
R. A. Alacron and J. Meienhofer, Formation of the cytotoxic aldehyde acrolein duringin vitro degradation of cyclophosphamide. Nature New Biol. 233, 250 (1971).
M. Colvin, C. A. Padgett, and C. Fenselau, A biologically active metabolite of cyclophosphamide. Cancer Res. 33, 915 (1973).
I. A. Rapoport, Mutations under the influence of unsaturated aldehydes, Dokl. Akad. NaukSSSR 61, 713 (1948).
D. L. Hill, W. R. Laster, Jr., M. C. Kirk, S. El Dareer, and R. F. Struck, Metabolism of ifosfamide and production of a toxic ifosfamide metabolite. Cancer Res. 33, 1016 (1973).
R. C. Garner, E. C. Miller, J. V. Garner, and R. S. Hanson, Formation of a factor lethal forS. typhimurium TA 1530 and TA 1531 on incubation of aflatoxin Bi with rat liver microsomes, Biochem. Biophys. Res. Commun. 45, 774 (1971).
R. C. Garner, E. C. Miller, and J. A. Miller, Microsomal metabolism of aflatoxin Bi to a reactive derivative toxic toSalmonella typhimurium TA 1530, Cancer Res. 32, 2058 (1972).
B. N. Ames, W. E. Durston, E. Yamasaki, and F. D. Lee, Carcinogens are mutagens: A simple test combining liver homogenates for activation and bacteria for detection, Proc. Nat. Acad. Sci. U.S.A. 70, 2281 (1973).
W. H. Butler, M. Greenblatt, and W. Lijinsky, Carcinogenesis by aflatoxins Bi, Gi, and Ba, Cancer Res. 29, 2206 (1969).
G. N. Wogan, G. S. Edwards, and P. M. Newberne, Structure-activity relationships in toxicity and carcinogenicity of aflatoxins and analogs. Cancer Res. 31, 1936 (1971).
T. Ong, Mutagenicity of aflatoxins in Neurospora crassa, Mutat, Res. 9, 615 (1970).
Tong-man Ong, and F. J. De Serres, Mutagenicity of chemical carcinogens in Neurospora crassa, Cancer Res. 32, 1890 (1972).
R. C. Garner, Microsome-dependent binding of aflatoxin Bi to DNA, RNA, polyribonucleotides and proteinsin vitro, Chem.-Biol. Interactions 6, 125 (1973).
H. L. Gurtoo, Binding of aflatoxins (Bi, B2, Gi, G2, and Bza) and metabolites to hepatic microsomes. Pharmacologist 15, 176 (1973).
H. L. Gurtoo and T. C. Campbell, Metabolism of aflatoxin Bi and metabolism-dependent and independent binding of aflatoxin Bi to rat hepatic microsomes, Mol. Pharmacol. 5, 635 (1973).
H. L. Gurtoo and C. V. Dave, In vitro metabolic conversion of aflatoxins and benzo(a)pyrene to nucleic acid-binding metabolites, Cancer Res. 35, 382 (1975).
C. C. J. Culvenor, A. T. Dann, and A. T. Dick, Alkylation as the mechanism by which the hepatotoxic pyrrolizidine alkaloids act on cell nuclei. Nature 195, 570 (1962).
C. C. J. Culvenor, D. T. Downing, J. A. Edgar, and M. V. Jago, Pyrrolizidine alkaloids as alkylating and antimitotic agents, Ann. N.Y. Acad. Sci. 163, 837 (1969).
A. R. Mattocks, Toxicity of pyrrolizidine alkaloids. Nature 217, 723 (1968).
L. B. Bull, C. C. J. Culvenor, and A. T. Dick, “The Pyrrolizidine Alkaloids,” North Holland Publishing Co., Amsterdam (1968).
R. Schoental, Liver lesions in young rats suckled by mothers treated with the pyrrolizidine (senecio) alkaloids lasiocarpine and retrorsine, J. Pathol. Bact. 77, 485 (1959).
R. Schoental, Liver disease and “natural” hepatoxins. Bull. W. H. O. 29, 823 (1963).
J. A. Miller and E. C. Miller, in:Potential Carcinogenic Hazards from Drugs, p. 209, Springer, Berlin (1967).
J. A. Miller and E. C. Miller, The metabolic activation of carcinogenic aromatic amines and amides. Prog. Exp. Tumor Res. 11, 273 (1969).
E. C. Miller and J. A. Miller, Studies on the mechanism of activation of aromatic amine and amide carcinogens to ultimate carcinogenic electrophilic reactants, Ann. N. Y. Acad. Sci. 163, 731 (1969).
E. K. Weisburger and J. H. Weisburger, Chemistry, carcinogenicity, and metabolism of N-2-nuorenamine and related compounds, Adv. Cancer Res. 5, 331 (1958).
H. R. Gutman, D. Malejka-Giganti, E.J. Barry, and R. E. Rydell, On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat. Cancer Res. 32, 1554 (1972).
Y. Yost, H. R. Gutman, and R. E. Rydell, The carcinogenicity of fluorenylhydroxamic acids and N-acetozy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophils. Cancer Res. 35, 447 (1975).
E. Boyland, Polycyclic hydrocarbons, Brit. Med. Bull. 20, 121 (1964).
H. V. A. Gelboin, in: “The Jerusalem Symposium on Quantum Chemistry and Biochemistry Physico-chemical mechanisms of Carcinogenesis” (E. D. Bergmann and B. Pullman, eds.), Vol. 1, p. 175 Israel. Acad. Sci. Hum., Jerusalem (1969).
P. L. Grover and P. Sims, Enzyme-catalyzed reactions of polycyclic hydrocarbons with DNA on protein in vitro, Biochem. J. 110, 159 (1969).
P. L. Grover, A. Hewer, and P. Sims, Formation of K-region epoxides as microsomal metabolites of pyrene and benzo(a)pyrene, Biochem. Pharmacol. 21 2713 (1972).
P. O. P. Ts’o, S. A. Lesko, and R. S. Umans, in: “The Jerusalem Symposium on Quantum Chemistry and Biochemistry. Physico-chemical Mechanisms of Carcinogenesis” E. D. Bergmann, and B. Pullman, eds.). Vol. 1, p. 106, Israel Acad. Sci. Hum., Jerusalem (1969).
J. Fried and D. E. Schümm, One-electron transfer oxidation of 7,12-dimethylbenz(a)anthracene, a model for the metabolic activation of carcinogenic hydrocarbons, J. Am. Chem. Soc. 89, 5508 (1967).
R. S. Umans, S. A. Lesko, Jr., and P. O. P. Ts’o, chemical linkage of carcinogenic 3,4-benzpyrene to DNA in aqueous solution induced by peroxide and iodine. Nature 221, 763 (1969).
M. Wilk and H. Schwab, Zum Transportphänomen und Wirkungsmechanismus des 3,4-Benzpyrens in der Zelle, Z. Naturforsch. 23b, 431 (1968).
S. C. Chang, P. H. Terry, C. W. Woods, and A. B. Borkovec, Metabolism of hempa uniformly labeled with C14 in male house flies, J. Econ. Entomot. 60, 1623 (1967).
A. R. Jones and H. Jackson, The metabolism of hexamethylphosphoramide and relatedcompounds, Biochem. Pharmacol. 17, 2247 (1968).
P. L. Viola, Carcinogenic effect of vinyl chloride, Abstr. 10th Int. Cancer Cong. Houston, Vol. 29.
J. L. Creech and M. N. Johnson, Angiosarcoma of the liver in the manufacture of Polyvinylchloride, J. Occup. Med. 16, 150(1974).
H. Bartsch, C. Malaveille, and R. Montesano, Human, rat and mouse liver-mediated mutagenicity of vinyl chloride in S. typhimurium strains, Int. J. Cancer 15, 429 (1975).
U. Rannug, A. Johansson, C. Ramel and C. A. Wachtmeister, The mutagenicity of vinyl chloride after metabolic activation, Ambio3, 194 (1974).
A. Ducatman, K. Hirschhorn, and I. J. Selikoff, Vinyl chloride exposure and human chromosome aberrations, Mutat. Res. 31, 163 (1975).
H. Bartsch and R. Montesano, Mutagenic and carcinogenic effects of vinyl chloride, Mutat. Res. 32, 93 (1975).
C. Malaveille, H. Bartsch, A. Barbin, A. M. Camus, R. Montesano, A. Croisy, and P. Jacquignon, Mutagenicity of vinyl chloride, chloroethylene oxide, chloroacetaldehyde and chloroethanol. Biochem. Biophys. Res. Commun. 63, 363 (1975).
G. F. Kolar, R. Fahrig, and E. Vogel, Structure-activity dependence in some novel ring-substituted 3, 3-dimethyl-l-phenyltriazenes. Genetic effects in Drosophila melanogaster and in Saccharomyces cerevisiae by a direct and a host-mediated assay, Chem.-Biol. Interactions 9, 365 (1974).
G. F. Kolar and J. Schlesiger, Urinary metabolites of l-aryl-3, 3-dimethyltriazenes in the rat (abstr.). Paper presented at the second meeting of the European Assoc. for Cancer Res., Heidelberg, Oct. 2–5, 1973, p. 246.
E. Vogel, Chemische konstitution und mutagene Wirkung. VI. Induktion dominanter und rezessiv-geschlechtsgebundener Letalmutationen durch Aryldialkyltriazene bei Drosophila melanogaster, Mutat. Res. 11, 397 (1971).
E. Vogel, R. Fahrig, and G. Ohe, Triazenes, a new group of indirect mutagens; comparative investigations of the genetic effects of different aryldialkyltriazenes using Saccharomyces cerevisiae, the host-mediated assay, Drosophila melanogaster, and human chromosomes in vitro, Mutat. Res. 21, 123 (1973).
O. G. Fahmy, M. J. Fahmy, J. Massasso, and M. Ondrej, Differential mutagenicity of the amine and amide derivatives of nitroso-compounds in Drosophila melanogaster, Mutat. Res. 3, 201 (1966).
O. G. Fahmy and M. J. Fahmy, Mutational mosaicism in relation to dose with the amine and amide derivatives of nitroso compounds in Drosophila melanogaster, Mutat. Res. 6, 139 (1968).
L. Pasternak, Mutagene Wirkung von Dimethylnitrosamin bei Drosophila melanogaster, Naturwissenschaften 49, 381 (1962).
L. Pasternak, Untersuchungen über die mutagene Wirkung von Nitrosaminen und Nitrosomethylharnstoff, Acta Biol. Med. Ger. 10, 436 (1963).
L. Pasternak, Untersuchungen über die mutagene Wirkung verschiedener Nitrosamin- und Nitrosamid-Verbindungen, Arzneim.-forsch. 14, 802 (1964).
E. Vogel and B. Leigh, Concentration-effect studies with MMS, TEB, 2,4,6-triCl-PDMT and DEN on the induction of dominant and recessive lethals, chromosome loss and translocations in Drosophila sperm, Mutat. Res. 29, 383 (1975).
E. Vogel, Strain variations in response to certain indirect mutagens in Drosophila melanogaster, Drosophila Inform. Serv. 50, 138 (1973).
C. Bertram and G. Höhne, Uber die radiomimetische Wirkung einiger Zytostatika im Mutationsversuch an Drosophila, Strahlentherapie 43, 386 (1959).
G. Röhrborn, Chemische Konstitution und mutagene Wirkung. IV. Zyklische N-Lostderivate, Mol. Gen. Genet. 102, 50 (1968).
E. Vogel, Specific mutagenic activity of cyclophosphamide, trofosfamide, and ifosfamide in Drosophila melanogaster, Mutat. Res. 33, 221 (1975).
H. Druckrey, R. Preussmann, D. Schmähl, and M. Müller, Chemische Konstitution und carcinogene Wirkung bei Nitrosaminen, Naturwissenschaften 48, 134 (1961).
M. J. Lamb and L. J. Lilly, Induction of recessive lethals in Drosophila melanogaster by aflatoxin Bi, Mutat. Res. 11, 430 (1971).
N. G. Brink, The effect of cyanide and azide on the mutagenic activity of the pyrrolizidine alkaloid heliotrine in Drosophila melanogaster, Z. Vererbungsl. 94, 331 (1963).
N. G. Brink, The mutagenic activity of heliotrine in Drosophila. 1. Complete and mosaic sex-linked lethals, Mutat. Res. 3, 66 (1966).
N. G. Brink, The mutagenic activity of the pyrrolizidine alkaloid heliotrine in Drosophila melanogaster. II. Chromosome rearrangements. Mutat. Res. 8, 138 (1969).
A. M. Clark, The mutagenic activity of some pyrrolizidine alkaloids in Drosophila, Z. Vererbungsl. 91, 74 (1960).
A. M. Clark, The brood pattern of sensitivity of theDrosophila testis to the mutagenic action of heliotrine, Z. Vererbungsl. 94, 115 (1963).
A. D. Tates, Cytodifferentiation during spermatogenesis in Drosophila melanogaster. Thesis, University of Leiden (1971).
A. Loveless,”Genetic and Allied Effects of Alkylating Agents,” Pennsylvania State University Pressxx (1966).
H. Lüers and G. Röhrborn, Chemische Konstitution und mutagene Wirkung. III. Äthylenimine, Mutat. Res. 2, 29 (1968).
E. Vogel and J. L. R. Chandler, Mutagenicity testing of cyclamate and some pesticides in Drosophila melanogaster, Experientia 30, 621 (1974).
L. W. Wattenberg and J. L. Leong, Histochemical demonstration of reduced pyridine nucleotide dependent polycyclic hydrocarbon metabolizing systems, J. Histochem. Cytochem. 10, 412 (1962).
M. Demerec, B. Wallace, E. M. Witkin, and G. Bertani, The gene, Carnegie Inst. Washington Yearb. 48, 156 (1949).
O. G. Fahmy and M.J. Fahmy, Specific genetic deletions by a carcinogenic hydrocarbon in Drosophila, Nature (London) 224, 1328 (1969).
O. G. Fahmy and M. J. Fahmy, Genetic deletions at specific loci by polycyclic hydrocarbons in relation to carcinogenesis, Int. J. Cancer 6, 250 (1970).
O. G. Fahmy and M.J. Fahmy, Gene elimination in carcinogenesis: Reinterpretation of the somatic mutation theory, Cancer Res. 30, 195 (1970).
O. G. Fahmy and M. J. Fahmy, Induction of bobbed (bb) mutations by polycyclic aromatic carcinogens in Drosophila, Mutat. Res. 9, 239 (1970).
O. G. Fahmy and M. J. Fahmy, Mutagenic selectivity for the RNA-forming genes in relation to the carcinogenicity of alkylating agents and polycyclic aromatics, Cancer Res. 32, 550(1972).
O. G. Fahmy and M. J. Fahmy, Mutagenic properties of N-acetyl-2-aminofluorene and its metabolites in relation to the molecular mechanisms of carcinogenesis. Int. J. Cancer 9, 284 (1972).
O. G. Fahmy, M. J. Fahmy, Genetic properties of substituted derivatives of N-methyl-4-aminobenzene in relation to azo-dye carcinogenesis. Int. J. Cancer 10, 194 (1972).
O. G. Fahmy and M. J. Fahmy, Mutagenic properties of benzo(a)pyrene and its methylated derivatives in relations to the molecular mechanisms of hydrocarbon carcinogenesis. Cancer Res. 33, 302 (1973).
O. G. Fahmy and M. J. Fahmy, Oxidative activation of benz(a)anthracene and methylated derivatives in mutagenesis and carcinogenesis. Cancer Res. 33, 2354 (1973).
J. W. Cramer, J. A. Miller, and E. C. Miller, N-hydroxylation: A new metabolic reaction observed in the rat with the carcinogen 2-acetylaminofluorene, J. Biol. Chem. 235, 885 (1960).
J. A. Miller, J. W. Cramer and E. C. Miller, The N- and ring-hydroxylation of 2-acetylaminofluorene during carcinogenesis in the rat. Cancer Res. 20, 950 (1960).
J. R. De Baun, J. Y. Rowley, E. C. Miller, and J. A. Miller, Sulfotransferase activation of N-hydroxy-2-acetylaminofluorene in rodent livers susceptible and resistant to this carcinogen, Proc. Soc. Exp. Biol. Med. 129, 268 (1968).
J. R. De Baun, E. C. Miller, and J. A. Miller, N-hydroxy-2-acetylaminofluorene sulfotransferase: Its probable role in carcinogens and in protein (methion-j-yl) binding in rat liver. Cancer Res. 30, 577 (1970).
J. H. Weisburger, R. S. Yamamoto, P. H. Grantham, and E. K. Weisburger, Evidence that sulphate esters are key ultimate carcinogens from N-hydroxy-N-2-fluorenylacetamide, Proc. Am. Assoc. Cancer Res. 11, 82 (1970).
R. J. Srám, The differences in the spectra of genetic changes in Drosophila melanogaster induced by chemosterilants TEPA and HEMPA, Folia Biol. (Prague) 18, 139 (1972).
O. G. Fahmy and M. J. Fahmy, Mutagenicity in the sperm of Drosophila and the structure of the “nitrogen-mustard” molecule, Heredity 15, 115 (1960).
E. R. Felix and V. M. Salceda, A technique for microinjection in Drosophila, Drosophila Inform. Serv. 39, 135 (1964).
E. R. Felix and R. Rodriguez, A microinjection technique for Drosophila, Drosophila Inform. Serv. 43, 180 (1968).
P. Mollet and F. E. Würgler, An apparatus to inject large numbers of Drosophila with constant amounts of fluid within a short time, Drosophila Inform. Service 50, 202 (1973).
R. L. Seecof, An injection apparatus for Drosophila, Drosophila Inform. Serv. 41, 185 (1966).
G. A. Sega and W. R. Lee, A vacuum injection technique for obtaining uniform dosages in D. melanogaster, Drosophila Inform. Serv. 45, 179 (1970).
A. J. Stocker, A simple microinjection apparatus forDrosophila, Drosophila Inform. Serv. 44, 124 (1969).
L. W. Shivertaker, The microinjection of Drosophila larvae, Drosophila Inform. Serv. 45, 188 (1970).
E. B. Lewis and F. Bacher, Method of feeding ethyl methane sulfonate (EMS) to Drosophila males, Drosophila Inform. Serv. 43, 193 (1968).
H. Lliers, Untersuchung iiber die Mutagenitat des Triäthylenmelamin (TEM) an Drosophila melanogaster, Archiv Geschwulstforschung 6, 11 (1953).
E. Vogel and H. Lüers, A comparison of adult feeding to injection in D. melanogaster, Drosophila Inform. Serv. 51, 113 (1974).
S. K. Hotchkiss and J. K. Lim, Mutagenic specificity of ethyl methanesulfonate affected by treatment methods, Drosophila Inform. Serv. 43, 116 (1968).
J. K. Lim and L. A. Snyder, The mutagenic effects of two monofunctional alkylating chemicals on mature spermatozoa of Drosophila, Mutat. Res. 6, 129 (1968).
Y. Fujita and U. Nakao, A test of mutagenicity and chromosome breaking ability of 4-nitroquinoline-N-oxide in D. melanogaster, Drosophila Inform. Serv. 37, 80 (1963).
Y. Nakao and Y. Morioka, A test of mutagenicity of 4-nitroquinoline-N-oxide in D. melanogaster, Drosophila Inform. Serv. 37, 110 (1963).
A. G. A. C. Knaap, and P. G. N. Kramers, Mutagenicity of hycanthone in Drosophila melanogaster, Mutat. Res. 22, 55 (1974).
G. A. Sega, P. A. Gee, and W. R. Lee, Dosimetry of the chemical mutagen ethyl methane sulfonate in spermatozoa DNA from Drosophila melanogaster, Mutat. Res. 16, 203 (1972).
D. L. Lindsley and E. H. Grell, Genetic variations of Drosophila melanogaster, Carnegie Inst. Washington Pubi, 627, 472 pp (1968).
C. Ramel, ed., Evolution of genetic risks of environmental chemicals, Ambio Special Report, Royal Swedish Academy of Sciences, No. 3 (1972), University of Stockholm.
Ch. Auerbach, Past achievements and future tasks of research in chemical mutagenesis, in Genetics Today (S. J. Geerts, ed.). Vol. 2, p. 275, Pergamon, London (1965).
I. H. Herskowitz, The incidence of chromosomal rearrangements and recessive lethal mutations following treatment of mature Drosophila sperm with 2, 4, 6-tri(ethylenimino)-1,3,5-triazine, Genetics 40, 574 (1955).
I. H. Herskowitz, Mutagenesis in mature Drosophila spermatozoa by “triazine” applied in vaginal douches, Genetics 41, 605 (1956).
W. E. Ratnayake, Effects of storage on dominant lethals induced by alkylating agents (triethylene melamine and ethylenimine), Mutat. Res. 5, 271 (1968).
W. Ratnayake, C. Strachan, and C. Auerbach, Genetical analysis of the storage effect of tiethylene melamine (TEM) on chromosome breakage in Drosophila, Mutat. Res. 4, 380 (1967).
A. Schalet, The relationship between the frequency of nitrogen mustard induced translocations in mature sperm of Drosophila and utilization of sperm by females, Genetics 40, 534 (1955).
H. Slizynska, The progressive approximation, with storage, of the spectrum of TEM-induced chromosomal changes in Drosophila sperm to that found after irradiation, Mutat. Res. 8, 165 (1969).
L. A. Snyder, Evidence of an essential difference between point mutations and chromosome breaks induced by triethylene melamine in Drosophila spermatozoa, Z. Vererbungsl. 94, 182 (1963).
W. A. F. Watson, Evidence of an essential difference between the genetical effects of mono- and bifunctional alkylating agents, Z. Vererbungsl. 95, 374 (1964).
W. A. F. Watson, Further evidence of an essential difference between the genetical effects of mono- and bifunctional alkylating agents, Mutat. Res. 3, 455 (1966).
S. Abrahamson, W. C. Kiriazis, and E. M. Sabol, A storage effect of ethylmethanesulfonate (EMS) on the induction of translocations in Drosophila sperm, Drosophila Inform. Serv. 44, 110 (1969).
R. J. Srâm The effect of storage on the frequency of dominant lethals in Drosophila melanogaster. Mol. Gen. Genet. 106, 286 (1970).
R. J. Srâm, The effect of storage on the frequency of translocations in Drosophila melanogaster, Mutat. Res. 9, 243 (1970).
C. Auerbach and E. M. Sonbati, Sensitivity of Drosophila testis to the mutagenic action of mustard gas, Z. Vererbungsl. 91, 237 (1960).
T. Alderson, Ethylation versus methylation in mutation ofEscherichia coli and Drosophila, Nature 203, 1404 (1964).
T. Alderson and M. Pelecanos, The mutagenic activity of diethyl sulphate in Drosophila melanogaster. II. The sensitivity of the immature (larval) and adult testis, Mutat. Res. 1, 182 (1964).
A. H. Khan, Effect of storage of alkylated chromosomes on the mutagenic effectiveness of monofunctional alkylation, Mutat. Res. 8, 565 (1969).
M. Pelecanos, Induction of cross-overs, autosomal recessive lethal mutations, and reciprocal translocations in Drosophila after treatment with diethyl sulfate, Nature (London) 210, 1294 (1966).
I. A. Rapoport, On the mutagenic action of dimethyl and diethyl sulphate, Dokl. Akad. Nauk SSSR 12, 12 (1947).
I. A. Rapoport, Chemical mutations in sex-chromosomes with a frequency above fifty per cent and increased proportions of semi-lethals, Dokl. Biol. Sci. 141, 1476 (1961).
S. S. Epstein and H. Shafner, Chemical mutagens in the human environment. Nature 219, 385 (1968).
P. Propping, C. Röhrborn, and W. Buselmaier, Comparative investigations on the chemical induction of point mutations and dominant lethal mutations in mice, Mol. Gen. Genet. 117, 197 (1972).
P. K. Datta and E. Schleiermacher, The effects of Cytoxan on the chromosomes of mouse bone marrow, Mutat. Res. 8, 623 (1969).
G. Röhrborn and I. Hansmann, Induced chromosome aberrations in unfertilized oocytes of mice. Hum. Genet. 13, 184 (1971).
E. Schleiermacher, Uber den Einfluss von Trenimon und Endoxan auf die Meiose der männlichen Maus. II. Cytogenetische Befunde nach Behandlung mit Trenimon und Endoxan, Hum. Genet. 3, 134 (1966).
W. Schmid, D. T. Arakaki, N. A. Breslau, and J. C. Culbertson, The Chinese hamster bone marrow as anin vivo test system. I. Cytogenetic results on basic aspects of the methodology, obtained with alkylating agents, Hum. Genet. 11, 103 (1971).
W. M. Generoso, W. L. Russell, Sandra W. Huff, Sandra K. Stocet, and D. C. Crosslee, Effects of dose on the induction of dominant-lethal mutations and heritable translocations with ethyl methanesulfonate in male mice. Genetics 77, 741 (1974).
B. E. Matter and W. M. Generoso, Effects of dose on the induction of dominant lethal mutations with triethylene melamine in male mice. Genetics 77, 753 (1974).
B. E. Matter, I. Jaeger, and J. Grauwiler, Experimental model systems in toxicology and their significance in man, Excerpta Med. Int. Congr. Ser. 311, 275 (1973).
B. E. Matter and J. Grauwiler, Micronuclei in mouse bone-marrow cells. A simplein vivo model for the evaluation of drug-induced chromosomal aberrations, Mutat. Res. 23, 239 (1973).
C. Auerbach, “Mutation. Part I. Methods,” p. 20, Oliver and Boyd, Edinburgh and London (1962).
A. J. Bateman and S. S. Epstein, Dominant lethal mutations in mammals, in:“Chemical Mutagens” (A. Hollaender, ed.), p. 541, Plenum Press, New York (1971).
G. Pontecorvo, The problem of dominant lethals, J. Genet. 43, 295 (1942).
S. Abrahamson and I. H. Herskowitz, Induced changes in female germ cells of Drosophila. II. Oviposition rate and egg mortality in relation to intensity and dosage of X-rays applied to oocytes. Genetics 42, 405 (1957).
K. Sankaranarayanan, The effects of nitrogen and oxygen treatments on the frequencies of X-ray-induced dominant lethals and on the physiology of the sperm in Drosophila melanogaster, Mutat. Res. 4, 641 (1967).
J. D. Telfer, An improved technique for dominant lethal studies in Drosophila, Am. Nat. 88, 117 (1954).
F. E. Würgler, U. Petermann, and H. Ulrich, A refined test for X-ray induced dominant lethals in Drosophila, Experientia 24, 1293 (1968).
O. G. Fahmy and M. J. Fahmy, Cytogenetic analysis of the action of carcinogens and tumor inhibitors in Drosophila melanogaster. II. The mechanism of induction of dominant lethals by 2,4,6-triethyleneimino-l,3,5-triazine, J. Genet. 52, 603 (1954).
G. E. Nasrat, W. D. Kaplan, and C. Auerbach, A quantitative study of mustard gas induced chromosome breaks and re-arrangements in Drosophila melanogaster. Z. Indukt. Abstamm. Vererbungsl. 86, 249 (1954).
L. A. Snyder and I. I. Oster, A comparison of genetic changes induced by a monofunctional and a polyfunctional alkylating agent in Drosophila melanogaster, Mutat. Res. 1, 437 (1964).
A. J. Bateman and A. C. Chandley, The sensitivity of the male germ cells ofDrosophila to methyl methanesulfonate. Heredity (London) 19, 711 (1964).
E. Vogel, Strong antimutagenic effects of fluoride on mutation induction by trenimon and l-phenyl-3, 3-dimethyltriazene in Drosophila melanogaster, Mutat. Res. 20, 339 (1973).
R. Slacik-Erben and G. Obe, Suppressive activity by fluoride on the induction of chromosome aberrations in human cells in vitro with alkylating agents, Mutat. Res. 19, 369 (1973).
R. N. Mukherjee and F. H. Sobels, The effect of sodium fluoride and iodoacetamide on mutation induction by X-irradiation in mature spermatozoa of Drosophila, Mutat. Res. 6, 217 (1968).
E. Vogel, Mutagenitatsuntersuchungen mit DDT und den DDT-Metaboliten DDE, DDD, DDOM und DDA an Drosophila melanogaster, Mutat. Res. 16, 157 (1972).
E. Vogel, Mutagenic activity of the insecticide oxydemetonmethyl in a resistant strain of Drosophila melanogaster, Experientia 30, 396 (1974).
F. H. Sobels, A comparison of the mutagenic effects of chemicals and ionizing radiation, in “Radiation Research—Biomedical, Chemical and Physical Perspectives,” 5th International Congress of Radiation Research, Seattle, Washington, July 14–20, 1974. Academic Press, New York, in press.
A. M. Clark, Mutagenic activity of the alkalid heliotrine in Drosophila, Nature (London) 183, 731 (1959).
L. M. Cook and A. C. E. Holt, Mutagenic activity in Drosophila of two pyrrolizidine alkaloids, J. Genet. 59, 273 (1966).
W. J. Burdette, Tumor incidence and lethal mutation rate in Drosophila treated with 20-methylcholanthrene, Cancer 72, 201 (1952).
R. J. Srám, The difference in the spectra of genetic changes in Drosophila melanogaster induced by chemosterilants TEPA and HEMPA, Folia Biol. (Prague) 18, 139 (1972).
E. A. Carlson and I.I. Oster, Chemical-mutagen induced mosaicism at the dumpy locus, Genetics 46, 856 (1961)
E. A. Carlson and I.I. Oster, Comparative mutagenesis of the dumpy locus in Drosophila melanogaster. II. Mutational mosaicism induced without apparent breakage by a monofunctional alkylating agent. Genetics, 47, 561 (1962).
J. L. Southin, An analysis of eight classes of somatic and gonadal mutation at the dumpy locus in Drosophila melanogaster, Mutat. Res. 3, 54 (1966).
I. I. Oster and E. Pooley, A comparison of the mutagenic effects of monofunctional and polyfunctional alkylating agents, Genetics 45, 1004 (1960).
L. S. Browning, Mutational spectrum in Drosophila after injection with nitrosoguanidine. Genetics 60, 165 (1968).
L. S. Browning, The mutational spectrum produced in Drosophila by N-methyl-N-nitro-N-nitrosoguanidine, Mutat. Res. 8, 157 (1969).
A. H. Khan, The mutagenic effect of nitrosoguanidine in Drosophila, Drosophila Inform. Serv. 43, 112(1968).
O. G. Fahmy and M. J. Bird, Chromosome breaks among recessive lethals induced by chemical mutagens in Drosophila melanogaster, Heredity 6 (Suppl.), 149 (1953).
O. G. Fahmy and M. J. Fahmy, Cytogenetic analysis of the actions of carcinogens and tumour inhibitors in Drosophila melanogaster. III. Chromosome structural changes induced by 2,4,6-triethylenimino-l,3,5-triazine, J. Genet. 53, 181 (1955).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Springer Science+Business Media New York
About this chapter
Cite this chapter
Vogel, E., Sobels, F.H. (1976). The Function of Drosophila in Genetic Toxicology Testing. In: Hollaender, A. (eds) Chemical Mutagens. Chemical Mutagens. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-0892-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-0892-8_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-0894-2
Online ISBN: 978-1-4684-0892-8
eBook Packages: Springer Book Archive